| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| velagluceras alfa 400 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| velagluceras alfa 200 enheter, frystorkat pulver till injektionsvätska |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| belimumab 400 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| belimumab 120 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| kanakinumab 150 mg, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| oktokog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| oktokog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| teduglutid 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| onabotulinumtoxin A 200 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| onabotulinumtoxin A 100 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| lurbinektedin 4 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| azacitidin 100 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| remimazolam (som remimazolambesilat) 20 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| Clostridium histolyticum-kollagenas 900 mikrog/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
| trilaciklib (som trilaciklibdihydroklorid) 300 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|